» Articles » PMID: 26297917

Contribution of β-cell Dysfunction and Insulin Resistance to Cirrhosis-associated Diabetes: Role of Severity of Liver Disease

Overview
Journal J Hepatol
Publisher Elsevier
Specialty Gastroenterology
Date 2015 Aug 23
PMID 26297917
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Background & Aims: This study evaluated the contribution of β-cell dysfunction and insulin resistance to cirrhosis-associated diabetes.

Methods: One-hundred and sixty cirrhotic patients with normal fasting plasma glucose (FPG), three with impaired fasting glucose and seven with untreated diabetes mellitus (DM) underwent an extended oral glucose tolerance test (OGTT). The OGTT data were analyzed with a Minimal Model to estimate dynamic (derivative) control (DC) and static (proportional) control (PC) of β-cell function, and with the Oral Glucose Insulin Sensitivity (OGIS)-2h index to estimate insulin sensitivity.

Results: Twenty-six patients (15.6%) had normal glucose tolerance (NGT), 60 (35.8%) had impaired glucose tolerance (IGT), and 84 (48.6%) had DM. DC was significantly reduced in DM vs. NGT and IGT patients. PC was significantly impaired in DM and IGT vs. NGT patients and in DM vs. IGT subjects. The OGIS-2h index was significantly reduced to a similar extent in DM and IGT vs. NGT patients. Patients with Child-Pugh class B and C cirrhosis had reduced DC and PC, but not OGIS-2h values, as compared with subjects in class A. Moreover, Child-Pugh class/score was an independent predictor of β-cell function even after adjustment for glucose tolerance.

Conclusions: Abnormalities of glucose tolerance occur frequently in cirrhosis even in patients with normal FPG, thereby supporting the importance of performing an OGTT. Transition from IGT to DM is driven primarily by β-cell dysfunction. Insulin secretion worsens in parallel with the severity of liver disease, thus suggesting a detrimental effect of liver failure on pancreatic islets on its own.

Citing Articles

Hepatogenous Diabetes as Compared to Type-2 Diabetes Mellitus and Non-diabetes in Patients With Liver Cirrhosis: Magnitude, Characteristics, and Implications.

Maji T, Mahto M, Kumar S, Anand U, Priyadarshi R, Arya R J Clin Exp Hepatol. 2024; 14(5):101411.

PMID: 38699514 PMC: 11061214. DOI: 10.1016/j.jceh.2024.101411.


Love-hate relationship between hepatitis B virus and type 2 diabetes: a Mendelian randomization study.

Yu Y, Tong K, Hu G, Yang X, Wu J, Bai S Front Microbiol. 2024; 15:1378311.

PMID: 38646627 PMC: 11026703. DOI: 10.3389/fmicb.2024.1378311.


From liver to hormones: The endocrine consequences of cirrhosis.

Quiroz-Aldave J, Gamarra-Osorio E, Durand-Vasquez M, Rafael-Robles L, Gonzales-Yovera J, Quispe-Flores M World J Gastroenterol. 2024; 30(9):1073-1095.

PMID: 38577191 PMC: 10989500. DOI: 10.3748/wjg.v30.i9.1073.


Intravoxel incoherent motion diffusion-weighted imaging for evaluating the pancreatic perfusion in cirrhotic patients.

Hu R, Zeng G, Fang Y, Nie L, Liang H, Wang Z Abdom Radiol (NY). 2023; 49(2):492-500.

PMID: 38052890 DOI: 10.1007/s00261-023-04063-0.


Effects of Liver Fibrosis on Islet Function in Patients with Chronic Hepatitis B Complicated with Impaired Fasting Glucose.

Lu Y, Gou W, Zhang H, Li Y Int J Gen Med. 2023; 16:5161-5173.

PMID: 38021063 PMC: 10640824. DOI: 10.2147/IJGM.S429455.